2013 American Transplant Congress
Serum Aldosterone and Graft Function in Prednisolone-Treated Renal Transplant Recipients
Background:Short-term outcome after kidney transplantation is excellent, but long-term survival is limited, with chronic transplant dysfunction as important contributor. The mineralocorticoid (MC) aldosterone is essential…2013 American Transplant Congress
Probability of a Positive AHG-CDC Crossmatch Is Determined by the Number, Strength, and Specificity of Donor-Specific Antibodies
Background: The factors determining the relationship between donor-specific antibodies (DSA) and the anti-human globulin complement-dependent cytotoxicity crossmatch (AHG-CDC XM) are not clearly defined. Canadian consensus…2013 American Transplant Congress
Treatment of Late Onset De Novo Donor Specific Antibody (DSA)-Mediated Pediatric Kidney Transplant Rejection with Bortezomib
Background: In pediatric renal transplantation late onset de novo DSA leading to antibody-mediated rejection (AMR) has a poor prognosis. Our disappointing results with IVIG, rituximab…2013 American Transplant Congress
Recipient Death and Graft Loss in Renal Transplantation: The Challenge of Infectious Complications
Hospital do Rim e Hipertensão, Sao Paulo, Brazil
Introduction: The causes of recipient death and renal allograft loss are still under evaluated, and there might be several differences according to the era of…2013 American Transplant Congress
Pregnancy Outcomes in Liver Recipients Transplanted for Biliary Atresia
The purpose of this study was to describe pregnancy outcomes in female liver recipients who received a transplant due to biliary atresia. Data were collected…2013 American Transplant Congress
IL-33 Expands ST2+ Regulatory T Cells Promoting Allograft Survival Directly and Indirectly through Actions on Myeloid Dendritic Cells
Background: IL-33 is an IL-1 cytokine that signals via ST2, which is expressed on both T cells and myeloid cells. IL-33 has been ascribed Th2…2013 American Transplant Congress
Role of eGFR Equations in Evaluating Deceased Donors for Kidney Transplantation: Sufficient and Appropriate Outcome Markers?
University of Turin, Chair of Nephrology, Turin, Italy
Donor evaluation is crucial in organ allocation for kidney graft, especially with the growing use of ECDs. Donor kidney function is decisive to predict graft…2013 American Transplant Congress
Results of a Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101, an Anti-TCR Monoclonal Antibody for the Prophylaxis of Acute Rejection in Kidney Transplantation
Purpose: Induction therapy using anti-lymphocytic antibodies is a potent tool for the prevention of early rejection after kidney transplantation. TOL-101, an IgM monoclonal antibody, with…2013 American Transplant Congress
Major Neurological Complications Following Renal Transplantation
Nephrology Division, Hospital do Rim e Hipertensão, Sao Paulo, Brazil
Introduction: Major neurological complications can add significant morbidity and mortality to renal transplant and have frequencies ranging from 6 to 30% in all transplant recipients.Objective:…2013 American Transplant Congress
Thrombin Generation and Platelet Activation in a Xenogenic Lung Perfusion Model Determine Survival of GalTKO.hCD46 Transgenic Lungs
Surgery, University of Maryland, Baltimore, MD; Revivicor, Inc., Blacksburg, VA
Purpose: As previously reported, the development of GalTKO pigs with additional expression of hCD46 has contributed to a significantly improved outcome of lungs in an…
- « Previous Page
- 1
- …
- 77
- 78
- 79
- 80
- 81
- …
- 178
- Next Page »